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Abstract
Background: Incomplete cervical cord syndrome without spinal instability is a very devastating event for the
patient and the family. It is estimated that up to 25% of all traumatic spinal cord lesions belong to this category.
The treatment for this type of spinal cord lesion is still subject of discussion. From a biological point of view early
surgery could prevent secondary damage due to ongoing compression of the already damaged spinal cord.
Historically, however, conservative treatment was propagated with good clinical results. Proponents for early
surgery as well those favoring conservative treatment are still in debate. The proposed trial will contribute to the
discussion and hopefully also to a decrease in the variability of clinical practice.
Methods/Design: A randomized controlled trial is designed to compare the clinical outcome of early surgical
strategy versus a conservative approach. The primary outcome is clinical outcome according to mJOA. This also
measured by ASIA score, DASH score and SCIM III score. Other endpoints are duration of the stay at a high care
department (medium care, intensive care), duration of the stay at the hospital, complication rate, mortality rate, sort
of rehabilitation, and quality of life. A sample size of 36 patients per group was calculated to reach a power of 95%.
The data will be analyzed as intention-to-treat at regular intervals, but the end evaluation will take place at two
years post-injury.
Discussion: At the end of the study, clinical outcomes between treatments attitudes can be compared. Efficacy,
but also efficiency can be determined. A goal of the study is to determine which treatment will result in the best
quality of life for the patients. This study will certainly contribute to more uniformity of treatment offered to
patients with a special sort of spinal cord injury.
Trial Registration: Gov: NCT01367405
Background
Traumatic Central Cord Syndrome (TCCS) was consi-
dered as a separate clinical entity. The most characteris-
tic feature is disproportionately more motor impairment
of the arms (especially the hands) than the legs, bladder
dysfunction and varying degrees of sensory loss below
the lesion.
Recently, it has been shown that the distinction of
TCCS with an incomplete cervical spinal cord lesion
(ICSCL) is artificial [1]. It is the most frequent incom-
plete traumatic spinal cord lesion. It accounts for up to
70% of all incomplete cervical spinal cord lesions [2],
although the exact incidence is not known.
Uncertainty exists about the treatment. A good reco-
very has been described after conservative treatment [3].
Conservative therapy was usually considered when a
fracture or dislocation of the spine was absent. It is often
seen in hyperextension trauma in the elderly, with a
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degenerative spondylotic stenotic cervical spine. How-
ever, some reports suggest a better outcome after surgi-
cal decompression [4]. Randomized trials have not been
performed.
Since the economic and emotional impact of a spinal
cord lesion is enormous, optimal treatment should be
instituted immediately after the traumatic event. To
provide more evidence in the choice of a treatment for
a specific traumatic spinal cord lesion, this study has
been designed.
Methods/Design
Ethical approval
The study has been approved by the regional ethical
board CMO Arnhem – Nijmegen.
Goal of the study
This study will evaluate two strategies to improve func-
tional outcome in patients with ICSCL without a fracture
or instability of the cervical spine: 1) early decompressive
surgery, and 2) conservative treatment.
Eponym
COSMIC is an eponym for Conservative or Surgical
treatment for Incomplete Cord lesion.
Definition ICSCL without spinal instability
ICSCL is an incomplete spinal cord lesion due to a cer-
vical spine trauma. Spinal instability is considered when
the criteria defined by White and Panjabi are present
[5]. At MRI and CT scanning with multiplanar recon-
struction signs are not seen that could indicate a fracture
of the cervical spine or instability. An overt sequestrated
herniated disc should not be present since this will
always necessitate immediate surgery. Involvement of
the cervical spinal cord should be established at physical
examination (symptomatic arm or hand dysfunction is
obligatory).
Surgical strategy
Several predictive factors for a good outcome have been
identified. One is the timing of surgery after the injury.
The debate about early versus late decompression is still
not closed. Early has been defined rather broadly from
less than 24 hours to less than 14 days [3,4,6].
From a biological point of view, it seems logical to
decompress a neural structure as soon as possible to
provide an optimal chance for recovery of the function.
Since most patients will not be directly referred to the
hospital where the surgical treatment will be offered,
time for transfer of the patient should be included.
Therefore in this study, early decompression is defined
as within 24 hours after the injury. A recent meta-
analysis on timing of decompressive procedures in cases
of traumatic spinal cord injuries accompanying spinal
fractures or dislocations, also considered a surgical de-
compression within 24 hours post-injury as early [7]. In
this trial, patients allocated to the surgical strategy will
be offered surgery within 24 hours post-injury. The main
goal of the surgery is adequate decompression of the
spinal cord.
Hypotheses
H0: In patients with ICSCL without spinal instability,
functional outcome for both strategies is the same.
H1: In patients with ICSCL without spinal instability,
the early surgical strategy improves functional outcome
compared to conservative treatment.
Patient selection
To avoid discussion about possible confounding or effect
modification related to the mechanism of trauma, this
study will focus on ICSCL in patients without fracture
or instability of the cervical spine on radiological
examinations. Instability is established with MRI, CT,
lateral and anteroposterior plain radiographs of the
spine. In case of doubt, radiographs in sitting position or
dynamic radiographs are made under direct supervision
of the treating surgeon.
Inclusion criteria: all adult patients with a history of a
traumatic event to the cervical spine fulfilling the criteria
of ICSCL.
Exclusion criteria: cognitive impairments, known neuro-
logical disease, psychiatric illness, significant co-morbidity
interfering with the indication to perform surgery or not,
use of anti-coagulating drugs, addiction to drugs or alco-
hol (more than five units daily), not speaking Dutch
language fluently, not willing to participate or partici-
pating in another trial.
Treatment allocation
After written informed consent has been obtained
patients will be randomized to either surgical or conser-
vative treatment. Informed consent should be obtained
within two hours after arrival at the emergency depart-
ment. Although no mode of treatment has been proven
superior to the other, surgical decompression may be
warranted during the conservative strategy treatment. It
is not considered as a failure but as a part of the conser-
vative strategy.
Interventions
Surgical treatment will consist of decompression of the
spinal cord by an anterior, posterior or combined
approach. The choice for the approach is made by the
treating surgeon. All participating surgeons are experien-
ced in spinal surgery. Fixation may be added to the
decompressive surgery according to the preference of
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the treating surgeon. Procedure and use of implants will
be documented. If a patient is allocated to the surgery
group it should be executed within 24 hours post-injury.
Postoperatively, an intensive rehabilitation program will
be prescribed. This will include exactly the same ele-
ments as for those patients who were allocated to the
conservative treatment.
Conservative treatment will consist of an intensive
rehabilitation program including physiotherapy and
ergotherapy. However, when a patient deteriorates after
24 hours post-injury, surgery may be indicated. This
decision is made by the treating physician. Should a
patient be operated upon after he has been located to
the conservative group, it is not considered as a failure
of the conservative strategy, but as a possible conse-
quence in case of deterioration.
Outcomes
Primary outcome: functional outcome at two years as
measured by validated Dutch translation of mJOA.
Secondary outcomes: motor and sensory scores accor-
ding to the ASIA standards at six weeks, 12 weeks, 12
months, duration of the stay at a high care department
(medium care, intensive care), duration of the stay at the
hospital, complication rate, mortality rate, sort of reha-
bilitation, quality of life, SCIM III, and arm/hand func-
tion assessed by the disability of the arm, shoulder and
hand questionnaire (DASH).
Furthermore, subjects keep a diary on the financial con-
sequences and health care consumption related to ICSCL.
Visits to the general practitioner, physical therapist,
medical specialists, alternative health practice, use of anal-
gesics, duration of sick leave from work and additional
utility/mobility costs are recorded. The patient’s or diaries
are returned during the outpatient clinic visits or by mail.
Scales
mJOA
The scale was developed for evaluation of impairments
related to degenerative spondylotic changes in the
cervical spine. Nevertheless, this scale is very useful
since it suitably describes the functional limitations of a
patient with compromised function of the cervical spinal
cord. The translation into the Dutch language has been
validated [8]. The minimal clinical important difference
has been estimated [9]. Since the patient can complete
the questionnaire himself, the scale is functional and
a minimal clinical important difference has been
estimated, the mJOA is used as a primary outcome
measurement.
SCIM III
The Spinal Cord Independence Measure (SCIM III) is
also a functional score that has been developed to
evaluate the functional recovery of patients with a spinal
cord lesion. It can be easily completed even by phone.
Recently, its reliability and validity has been shown [10]
however, a minimal clinical important difference has not
been established.
ASIA
The score of the American Spinal Injury association
(ASIA score) is the most frequently used scale to grade
neurological level and the severity of spinal cord injury.
The ASIA motor score represents the muscle strength of
determined muscles in arms and legs and the ASIA sen-
sory score represents the light touch and pin-prick sen-
sory functions within all dermatomes. The score is
reduced to upper extremity motor score (range 0–50),
lower extremity motor score (range 0–50) and sensory
score (range 0–112).
EuroQol 5QD (EQ-5D)
EQ-5D is a standardized health-related quality of life
questionnaire that can be applied to a wide range of
health conditions and treatments. It is designed for self-
completion by respondents. It consists of a descriptive
part compromising five dimensions: mobility, self-care,
usual activities, pain/discomfort and anxiety/depression,
and a VAS score indicating the self- rated health on a 20
cm VAS scale.
DASH
The DASH was developed as a 30-item questionnaire to
be completed by the patient to assess functional status
for clinical use in daily practice or as a research tool.
DASH evaluates symptoms and physical function with a
five-response option for each item. It has been proven to
be a reliable and valid instrument to assess disability in
patients with a variety of upper limb disorders [11]. The
Dutch translation has been validated [12].
Evaluation patients
The nature of the treatment under in the study prevents
a completely blind evaluation of the outcome. Therefore,
an independent observer trained in neurological exa-
minations, will perform the physical examination at each
follow- up visit. He/she will also complete the ques-
tionnaires and check the self-assessed questionnaires on
completeness (Table 1). The independent observer will
not participate in the initial admission, randomization
and treatment of the patient.
Data collection
Data will be collected during/each patient contact
through an internet based database. Investigators have
access to data, but do not have the possibility to check
the results during the trial. Neither do they have any
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possibility to correct data. If required, data can be
changed by an independent supervisor of the database.
Design
The study has been designed as a multi-centre, open,
randomized controlled trial. Participating centres should
have adequate experience with the treatment of patients
with spinal cord trauma and neurosurgical facilities
should be available on a 24 hours-a-day basis. All pri-
mary analyses will be performed on an intention-to-treat
basis comparing the two strategies.
Randomization
To improve the balance in the number of treatment
assignments in each participating centre, randomization
will be performed in blocks. A computer generated list
of treatment allocation is used for randomization. Treat-
ment assignment is made by secure computer access.
Sample size
Power calculations are hampered by the scarcity of data
on clinical outcome in this patient group. The mini-
mal clinically important difference in mJOA has been
estimated in an earlier trial [9,13]. A difference of at
least two points on the modified JOA functional score is
considered significant. The difference is expected to be
mainly allocated to the function of the arms and legs.
Based on literature, a standard deviation of 2 is assumed.
This estimate was confirmed by asking three experienced
cervical spine surgeons (members of the board of the
CSRS-es).
The sample size is calculated as follows: a two group
student test with a 0.05 two sided significance level and
a power of 95 % will need a sample size per group of 27
to detect a significant difference. Considering a ten
percent loss in follow up a total of 30 individuals per
group need to be included.
During the conservative treatment some patients will
require surgical decompression due to for example
neurological deterioration. It is estimated that it will occur
in 20% of the patients. Although this is not considered a
failure of treatment, the sample is increased to 36 patients
per group in order to maintain the same power.
Only patients allocated to the conservative group who
are offered surgery within 24 hours post-trauma, are
considered crossovers. This number is expected to be
very low. However, after completion of the trial this will
be evaluated and a separate per-protocol analysis
performed if significant cross over occurred.
Five centres in the Netherlands will participate and is
estimated that its conclusion will be within 2 years.
Statistical analysis
Baseline characteristics are reported using descriptive
statistics. Any imbalance characteristics found visually
will be account for in analysis of primary outcome.
Since the primary outcome of the two strategies is
compared after two years, a test for independent samples
will be used (student-t test). To see if differences at all
time points are present, these are assessed by computing
both the main effect of the treatment and the interaction
between treatment and time in a mixed linear model.
Discussion
Although already described in 1887 [14], traumatic
central cord lesion has first been defined by Schneider in
1954 [15]. It was characterized by disproportionately
more motor deficit of the arms and especially the hands
than the legs, bladder dysfunction and varying degrees
of sensory loss below the lesion. It was most frequently
seen in hyperextension injuries causing squeezing or
pinching of the spinal cord both anteriorly and poster-
iorly. Since its definition it was considered as a separate
entity. Recently, it was shown that it is just a form of in-
complete spinal cord lesion [1] therefore we abandoned
the use of the term traumatic central cord syndrome.
Since the description of traumatic central cord syn-
drome its treatment has been the subject of discussion.
Table 1 Study measurements over time
Admission 6 weeks post-injury 12 weeks post-injury 12 months post-injury 24 months post-injury
Patient demographics X
ASIA X X X X
mJOA X X X X X
SCIM III X X X X X
DASH X X X X
EQ-5D X X X X X
Patient diary X X X X X
Complication registration X X X X
MRI X
CT with reconstruction X
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In 1954 surgical decompression was even contraindi-
cated because spontaneous improvement or complete
recovery may occur [15]. At this moment either surgical
decompression or conservative treatment are favoured.
If a surgical decompression is chosen, the timing of the
procedure is also debated.
From a biological standpoint early decompression
seemed to be the most effective due to the prevention of
secondary damage [16]. In this study early surgery is
defined as decompression within 24 hours. Due to refer-
ral patterns it was thought that a more strict time sched-
ule would negatively interfere with the inclusion of the
patients. The operative approach to decompress will be
dependent on the surgeon. It is thought that the
approach does not contribute to the clinical effect as
long as the spinal cord is decompressed effectively.
In this study, surgical decompression is solely compa-
red to a standardized conservative treatment. The con-
servative treatment offered in both treatment arms will
be equal.
As primary endpoint the score at the translated mJOA
was chosen. Although it was developed for evaluation of
symptomatic cervical myelopathy due to degenerative
changes, its simplicity and the evaluation of the func-
tional impairment by the mJOA justified the choice
above the others. The scale is completed with the help
of the patient or even by the patient self. The mJOA
addresses the function of the upper limbs, lower limbs
and urinary sphincter. In fact, the signs and symptoms
of cervical spondylotic myelopathy resemble those of an
incomplete spinal cord lesion. Furthermore, functional
outcome is the most important for the patient treated
for a spinal cord lesion as it will directly influence his/
her quality of life.
The ASIA score has been designed for the evaluation
of traumatic spinal cord lesion, however it was not a
functional score. On the other hand, SCIM III has
recently been developed to evaluate the functional
impairment [10]. However, the experience with the scale
is limited and a clinically minimal important difference
has not been established. It will be measured at each
visit and its value in comparison to the other scales,
including the scales for quality of life, will be established.
Since the function of the hand is generally more
affected than the function of the lower limbs in ICSCL,
extra attention is given to a more specific test for study-
ing the function of the hand. For this purpose, a ques-
tionnaire to be self assessed was chosen, DASH. Apart
from the self assessment the validation of the translation
into Dutch is an advantage.
The major goal of the study will be to compare clinical
outcome measured by functional scales and quality of
life scales between two established treatment options.
Parallel to this objective, direct and indirect costs will be
evaluated from a societal perspective. Analysis of clinical
outcome in relation to costs is part of the study.
Several problems may arise. The recruitment of
patients may be hampered by the emotional distress dur-
ing the time that the patient must be included. In
addition to an informed consent form a legal representa-
tive is also required, but this does not preclude a delay
in the inclusion since the legal representative may be in
emotional distress as well. Furthermore, MRI may
disclose findings like hemorrhage within ligaments or
discs or other abnormalities suggesting instability. Even
if instability is not shown on the standard radiographs,
surgeons might be willing to offer the patient surgery.
Although a patient could have been included in the trial,
surgeons’ preference prohibited inclusion. Participating
surgeons are encouraged to follow the protocol. In case
of doubt, the project leader is always willing to deliber-
ate the case including the findings at radiographs. How-
ever, it cannot be prevented that potential candidates are
sometimes not included due to a surgeon’s preference.
The freedom to choose for a surgical approach including
the use of implants may interfere with the results. How-
ever, since every patient is unique a standard approach
cannot be given. Therefore, a more pragmatic approach
is chosen requiring adequate decompression of the
spinal cord.
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